Evidence map›Paper›PMID 36225283›Full record

ArticleProstate international2022

Non-infectious complications following transrectal prostate needle biopsy - Outcomes from over 8000 procedures.

Adrian Sosenko, Russell G Owens, Ae Lim Yang, Ahmad Alzubaidi, Thomas Guzzo, Edouard Trabulsi, John Danella, Gregory Diorio, Adam Reese, Jeffrey Tomaszewski and 7 more

Open access · goldAbstract read
In one paragraph

Article in Prostate international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Adrian SosenkoDepartment of Urology, Penn State Health, Hershey, PA, USA.
Russell G OwensPenn State College of Medicine, Hershey, PA, USA.
Ae Lim YangPenn State College of Medicine, Hershey, PA, USA.
Ahmad AlzubaidiDepartment of Urology, Penn State Health, Hershey, PA, USA.
Thomas GuzzoDivision of Urology, University of Pennsylvania Health System, Philadelphia, PA, USA.
Edouard TrabulsiSidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
John DanellaDepartment of Urology, Geisinger Surgery Institute, Danville, PA, USA.
Gregory DiorioMidLantic Urology, Main Line Health Physician Partners, Bala Cynwyd, PA, USA.
Adam ReeseDepartment of Urology, Temple Health, Philadelphia, PA, USA.
Jeffrey TomaszewskiDivision of Urology, MD Anderson Cancer Center at Cooper, Camden, NJ, USA.
Serge GinzburgDepartment of Urology, Einstein Health Care Network, Philadelphia, PA, USA.
Marc SmaldoneDepartment of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Claudette FonshellHealth Care Improvement Foundation, Philadelphia, PA, USA.
Kaynaat SyedHealth Care Improvement Foundation, Philadelphia, PA, USA.
Bruce JacobsDepartment of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Eric A SingerSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Jay D RamanDepartment of Urology, Penn State Health, Hershey, PA, USA.
Penn State Milton S. Hershey Medical Center · USEinstein Healthcare Network · USFox Chase Cancer Center · USMain Line Health · USRutgers, The State University of New Jersey · USTemple University · USThomas Jefferson University · USUniversity of Pennsylvania Health System · USUniversity of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prostate needle biopsy (PNB) remains the referent standard for diagnosing prostate cancer. Contemporary data highlight an increase in PNB-related infections particularly when performed transrectally. Non-infectious complications, however, may similarly contribute to biopsy-related morbidity. We review the incidence and predictors of non-infectious complications following transrectal PNB in a large statewide quality registry. Methods: Transrectal ultrasound-guided prostate needle biopsies performed between 2015 and 2018 were retrospectively reviewed. The incidence and distribution of non-infectious complications were annotated. Clinical, demographic, and biopsy variables of interest were evaluated by logistic regression for potential association with specific types of non-infectious complications. Results: Of 8,102 biopsies, 277 (3.4%) biopsies had reported post-procedure complications including 199 (2.5%) non-infectious and 78 (0.9%) infectious. Among the non-infectious complications, the most common events included urinary or rectal bleeding (74; 0.9%), urinary retention (70, 0.9%), vasovagal syncope (13, 0.2%), and severe post-operative pain (10, 0.1%). Approximately 56% of these non-infectious complications required an Emergency Department visit (111/199) and 27% (54/199) hospital admission for monitoring. Increasing transrectal ultrasound prostate volume was associated with post-procedure urinary retention (Odds ratio (OR) 1.07, 1.02-1.11, p = 0.002). No specific variables noted association with post-biopsy bleeding. Conclusion: Non-infectious complications occurred 2.5 times more often than infectious complications following transrectal ultrasound prostate needle biopsies. Larger prostate size was associated with a greater risk of post-procedure urinary retention. These data originating from experience from over 100 urologists across different health systems provide an important framework in counseling patients regarding expectations following transrectal prostate biopsy.

Indexed as

BiopsyComplicationsNon-infectiousProstate

Identifiers

PMID36225283
PMCPMC9520411
OpenAlexW4224940999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.